Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 2 , Pages 200-203 , February 2010

Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis

  • Ronen Ben-Ami

      Affiliations

    • Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-713-745-1371; fax: +1-713-745-6839.
    • ,
  • P. Rocco LaSala

      Affiliations

    • Department of Laboratory Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA
    • ,
  • Russell E. Lewis

      Affiliations

    • Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
    • College of Pharmacy, University of Houston, Houston, TX, USA
    • ,
  • Dimitrios P. Kontoyiannis

      Affiliations

    • Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
    • College of Pharmacy, University of Houston, Houston, TX, USA

Received 29 June 2009 ,Accepted 20 September 2009.

References 

  1. Aceti A, Corvaglia L, Faldella G. Infant formulas thickened with carob bean gum causing false-positive galactomannan test reactivity. Pediatr. Infect. Dis. J. 2008;27:769
  2. Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J. Antimicrob. Chemother. 2008;61:411–416
  3. Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J. Clin. Microbiol. 2006;44:389–394
  4. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin. Infect. Dis. 2009;48:1033–1041
  5. Bonini A, Capatti C, Parmeggiani M, Gugliotta L, Micozzi A, Gentile G, et al. Galactomannan detection in Geotrichum capitatum invasive infections: report of 2 new cases and review of diagnostic options. Diagn. Microbiol. Infect. Dis. 2008;62:450–452
  6. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica. 2006;91:986–989
  7. Cummings JR, Jamison GR, Boudreaux JW, Howles MJ, Walsh TJ, Hayden RT. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn. Microbiol. Infect. Dis. 2007;59:113–115
  8. Dalle F, Charles PE, Blanc K, Caillot D, Chavanet P, Dromer F, et al. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J. Clin. Microbiol. 2005;43:2929–2931
  9. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 2008;46:1813–1821
  10. Gangneux JP, Lavarde D, Bretagne S, Guiguen C, Gandemer V. Transient Aspergillus antigenaemia: think of milk. Lancet. 2002;359:1251
  11. Giacchino M, Chiapello N, Bezzio S, Fagioli F, Saracco P, Alfarano A, et al. Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum. J. Clin. Microbiol. 2006;44:3432–3434
  12. Huang YT, Hung CC, Hsueh PR. Aspergillus galactomannan antigenemia in penicilliosis marneffei. AIDS. 2007;21:1990–1991
  13. Huang YT, Hung CC, Liao CH, Sun HY, Chang SC, Chen YC. Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. J. Clin. Microbiol. 2007;45:2858–2862
  14. Kappe R, Schulze-Berge A. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J. Clin. Microbiol. 1993;31:2489–2490
  15. Mattei D, Rapezzi D, Mordini N, Cuda F, Lo NC, Musso M, et al. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin–clavulanic acid treatment. J. Clin. Microbiol. 2004;42:5362–5363
  16. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 2004;4:349–357
  17. Mennink-Kersten MA, Ruegebrink D, Klont RR, Warris A, Gavini F, Op den Camp HJ, et al. Bifidobacterial lipoglycan as a new cause for false-positive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J. Clin. Microbiol. 2005;43:3925–3931
  18. Racil Z, Kocmanova I, Lengerova M, Winterova J, Mayer J. Intravenous PLASMA-LYTE as a major cause of false-positive results of Platelia Aspergillus test for galactomannan detection in serum. J. Clin. Microbiol. 2007;45:3141–3142
  19. Stynen D, Sarfati J, Goris A, Prevost MC, Lesourd M, Kamphuis H, et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect. Immun. 1992;60:2237–2245
  20. Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N. Engl. J. Med. 2003;349:2366–2367
  21. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J. Clin. Microbiol. 1997;35:257–260
  22. Upton A, Marr KA. Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient. Curr. Infect. Dis. Rep. 2006;8:434–441
  23. Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R, Kelaher A, et al. Detection of galactomannan antigenemia in patients receiving piperacillin–tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J. Clin. Microbiol. 2004;42:4744–4748
  24. Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur. J. Clin. Microbiol. Infect. Dis. 2008;27:245–251
  25. Wheat LJ, Hackett E, Durkin M, Connolly P, Petraitiene R, Walsh TJ, et al. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin. Vaccine Immunol. 2007;14:638–640
  26. Xavier MO, Pasqualotto AC, Cardoso IC, Severo LC. Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay. Clin. Vaccine Immunol. 2009;16:132–133

PII: S0732-8893(09)00401-5

doi: 10.1016/j.diagmicrobio.2009.09.015

Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 2 , Pages 200-203 , February 2010

Article Tools

* Image Usage & Resolution